253 related articles for article (PubMed ID: 24530099)
1. The eosinophil surface receptor epidermal growth factor-like module containing mucin-like hormone receptor 1 (EMR1): a novel therapeutic target for eosinophilic disorders.
Legrand F; Tomasevic N; Simakova O; Lee CC; Wang Z; Raffeld M; Makiya MA; Palath V; Leung J; Baer M; Yarranton G; Maric I; Bebbington C; Klion AD
J Allergy Clin Immunol; 2014 May; 133(5):1439-47, 1447.e1-8. PubMed ID: 24530099
[TBL] [Abstract][Full Text] [Related]
2. Sialic acid-binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies.
Legrand F; Cao Y; Wechsler JB; Zhu X; Zimmermann N; Rampertaap S; Monsale J; Romito K; Youngblood BA; Brock EC; Makiya MA; Tomasevic N; Bebbington C; Maric I; Metcalfe DD; Bochner BS; Klion AD
J Allergy Clin Immunol; 2019 Jun; 143(6):2227-2237.e10. PubMed ID: 30543818
[TBL] [Abstract][Full Text] [Related]
3. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor.
Hamann J; Koning N; Pouwels W; Ulfman LH; van Eijk M; Stacey M; Lin HH; Gordon S; Kwakkenbos MJ
Eur J Immunol; 2007 Oct; 37(10):2797-802. PubMed ID: 17823986
[TBL] [Abstract][Full Text] [Related]
4. ADGRE1 (EMR1, F4/80) Is a Rapidly-Evolving Gene Expressed in Mammalian Monocyte-Macrophages.
Waddell LA; Lefevre L; Bush SJ; Raper A; Young R; Lisowski ZM; McCulloch MEB; Muriuki C; Sauter KA; Clark EL; Irvine KM; Pridans C; Hope JC; Hume DA
Front Immunol; 2018; 9():2246. PubMed ID: 30327653
[TBL] [Abstract][Full Text] [Related]
5. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders.
Heinisch IV; Bizer C; Volgger W; Simon HU
J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378
[TBL] [Abstract][Full Text] [Related]
6. Siglec-7 on peripheral blood eosinophils: Surface expression and function.
Legrand F; Landolina N; Zaffran I; Emeh RO; Chen E; Klion AD; Levi-Schaffer F
Allergy; 2019 Jul; 74(7):1257-1265. PubMed ID: 30690753
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.
Schmid-Grendelmeier P; Altznauer F; Fischer B; Bizer C; Straumann A; Menz G; Blaser K; Wüthrich B; Simon HU
J Immunol; 2002 Jul; 169(2):1021-7. PubMed ID: 12097410
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of an anti-eosinophil monoclonal antibody that recognizes granulocytes from patients with blood eosinophilia but not from subjects without eosinophilia.
Ochiai K; Iwamoto I; Takahashi H; Yoshida S; Nakagawa N; Tomioka H; Yoshida S
Clin Exp Immunol; 1991 May; 84(2):283-8. PubMed ID: 2025954
[TBL] [Abstract][Full Text] [Related]
9. Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome.
Caldwell JM; Collins MH; Stucke EM; Putnam PE; Franciosi JP; Kushner JP; Abonia JP; Rothenberg ME
J Allergy Clin Immunol; 2014 Nov; 134(5):1114-24. PubMed ID: 25234644
[TBL] [Abstract][Full Text] [Related]
10. Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
[TBL] [Abstract][Full Text] [Related]
11. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700.
Kim YJ; Prussin C; Martin B; Law MA; Haverty TP; Nutman TB; Klion AD
J Allergy Clin Immunol; 2004 Dec; 114(6):1449-55. PubMed ID: 15577851
[TBL] [Abstract][Full Text] [Related]
12. IL-5 receptor α levels in patients with marked eosinophilia or mastocytosis.
Wilson TM; Maric I; Shukla J; Brown M; Santos C; Simakova O; Khoury P; Fay MP; Kozhich A; Kolbeck R; Metcalfe DD; Klion AD
J Allergy Clin Immunol; 2011 Nov; 128(5):1086-92.e1-3. PubMed ID: 21762978
[TBL] [Abstract][Full Text] [Related]
13. The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition.
Kobayashi Y; Chu HH; Bui DV; Yun Y; Nguyen LM; Mitani A; Suzuki K; Asako M; Kanda A; Iwai H
Cells; 2023 Nov; 12(23):. PubMed ID: 38067174
[TBL] [Abstract][Full Text] [Related]
14. Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.
Stein ML; Villanueva JM; Buckmeier BK; Yamada Y; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2008 Jun; 121(6):1473-83, 1483.e1-4. PubMed ID: 18410960
[TBL] [Abstract][Full Text] [Related]
15. Indomethacin inhibits eosinophil migration to prostaglandin D2 : therapeutic potential of CRTH2 desensitization for eosinophilic pustular folliculitis.
Kataoka N; Satoh T; Hirai A; Saeki K; Yokozeki H
Immunology; 2013 Sep; 140(1):78-86. PubMed ID: 23582181
[TBL] [Abstract][Full Text] [Related]
16. Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease.
Kuang FL; De Melo MS; Makiya M; Kumar S; Brown T; Wetzler L; Ware JM; Khoury P; Collins MH; Quezado M; Pittaluga S; Klion AD
J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1598-1605.e2. PubMed ID: 35283330
[TBL] [Abstract][Full Text] [Related]
17. [An anti-human eosinophil monoclonal antibody AE500 that reacts only with granulocytes from hypereosinophilic patients].
Ochiai K; Iwamoto I; Kimura A; Nakagawa N; Tomioka H; Yoshida S; Takahashi H; Yoshida A
Arerugi; 1990 May; 39(5):459-64. PubMed ID: 2393351
[TBL] [Abstract][Full Text] [Related]
18. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
[TBL] [Abstract][Full Text] [Related]
19. Deposits of eosinophil granule proteins in eosinophilic cholecystitis and eosinophilic colitis associated with hypereosinophilic syndrome.
Tajima K; Katagiri T
Dig Dis Sci; 1996 Feb; 41(2):282-8. PubMed ID: 8601370
[TBL] [Abstract][Full Text] [Related]
20. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
